| Mark L. Tong, Md Inc. | |
|
1000 Fowler Way Suite 1a Placerville CA 95667-5738 | |
| (530) 344-9200 | |
| (530) 344-9010 |
| Full Name | Mark L. Tong, Md Inc. |
|---|---|
| Speciality | Family Medicine |
| Location | 1000 Fowler Way, Placerville, California |
| Authorized Official Name and Position | Mark Lex Tong (CEO) |
| Authorized Official Contact | 5303449200 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Mark L. Tong, Md Inc. 1000 Fowler Way Suite 1a Placerville CA 95667-5738 Ph: (530) 344-9200 | Mark L. Tong, Md Inc. 1000 Fowler Way Suite 1a Placerville CA 95667-5738 Ph: (530) 344-9200 |
| NPI Number | 1558388231 |
|---|---|
| Provider Enumeration Date | 07/17/2006 |
| Last Update Date | 08/22/2020 |
| Medicare PECOS PAC ID | 0941201818 |
|---|---|
| Medicare Enrollment ID | O20070118000596 |
News Archive
It's been more than 20 years since scientists first discovered the gene that causes cystic fibrosis (CF), yet questions about how the mutated gene causes disease remain unanswered.
Young scientists from SibFU together with their colleagues from FRC KSC SB RAS are developing a technology for creating multilayer gilded nanodisks for targeted drug delivery and treating malignant tumors using dip pen nanolithography.
Ivantis announced the enrollment of the first patient in the Hydrus IV study today. The Hydrus Microstent is the world's first intracanalicular scaffold for treatment of primary open angle glaucoma, a disease that afflicts over 70 million people worldwide and approximately 3 million people in the United States.
Texas Gov. Rick Perry was interrupted during a budget speech Tuesday by protesters demanding he expand Medicaid.
Scientists at Hokkaido University and collaborators have identified how inflammatory changes in tumors caused by chemotherapy trigger blood vessel anomalies and thus drug-resistance, resulting in the poor prognosis of cancer patients.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558388231 | NPI | - | NPPES |
| G080662 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | G80662 (California) | Primary |
| Provider Name | Mark L Tong |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1851467880 PECOS PAC ID: 1850392721 Enrollment ID: I20070118000599 |
News Archive
It's been more than 20 years since scientists first discovered the gene that causes cystic fibrosis (CF), yet questions about how the mutated gene causes disease remain unanswered.
Young scientists from SibFU together with their colleagues from FRC KSC SB RAS are developing a technology for creating multilayer gilded nanodisks for targeted drug delivery and treating malignant tumors using dip pen nanolithography.
Ivantis announced the enrollment of the first patient in the Hydrus IV study today. The Hydrus Microstent is the world's first intracanalicular scaffold for treatment of primary open angle glaucoma, a disease that afflicts over 70 million people worldwide and approximately 3 million people in the United States.
Texas Gov. Rick Perry was interrupted during a budget speech Tuesday by protesters demanding he expand Medicaid.
Scientists at Hokkaido University and collaborators have identified how inflammatory changes in tumors caused by chemotherapy trigger blood vessel anomalies and thus drug-resistance, resulting in the poor prognosis of cancer patients.
› Verified 6 days ago
News Archive
It's been more than 20 years since scientists first discovered the gene that causes cystic fibrosis (CF), yet questions about how the mutated gene causes disease remain unanswered.
Young scientists from SibFU together with their colleagues from FRC KSC SB RAS are developing a technology for creating multilayer gilded nanodisks for targeted drug delivery and treating malignant tumors using dip pen nanolithography.
Ivantis announced the enrollment of the first patient in the Hydrus IV study today. The Hydrus Microstent is the world's first intracanalicular scaffold for treatment of primary open angle glaucoma, a disease that afflicts over 70 million people worldwide and approximately 3 million people in the United States.
Texas Gov. Rick Perry was interrupted during a budget speech Tuesday by protesters demanding he expand Medicaid.
Scientists at Hokkaido University and collaborators have identified how inflammatory changes in tumors caused by chemotherapy trigger blood vessel anomalies and thus drug-resistance, resulting in the poor prognosis of cancer patients.
› Verified 6 days ago
Keith Boston, M.d. Family Practice Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3150 Gilmore St, Placerville, CA 95667 Phone: 530-622-4884 Fax: 530-622-1303 | |
Barba Family Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 899 Spring St, Placerville, CA 95667 Phone: 530-621-3600 Fax: 530-621-3668 | |
El Dorado County Community Health C Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4212 Missouri Flat Rd, Placerville, CA 95667 Phone: 530-621-7700 Fax: 530-621-7713 | |
Hall Chiropractic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 183 Placerville Dr Ste A, Placerville, CA 95667 Phone: 530-622-8041 | |
Precision Eyecare Optometry Placerville Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 118 Main St, Placerville, CA 95667 Phone: 530-622-8300 Fax: 530-622-8304 | |
El Dorado County Health Department Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 931 Spring Street, Placerville, CA 95667 Phone: 530-621-6100 Fax: 530-295-2501 | |
Foothills Extended Care Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1040 Marshall Way, Placerville, CA 95667 Phone: 201-772-4430 |